col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
World Scientific : Journal of Computational Biophysics and Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2026―May―15 Novel Indole Containing Thiadiazole and Oxadiazole Derivatives Targeting SARS-CoV-2 Papain-Like Protease Inhibitors: A Versatile Approach for Combined In-Vitro and In-Silico Validation Maher S. Alwethaynani, Maham Nadeem, Hina Sarfraz, Khuram Ashfaq, Tahir Ali Chohan, Rafaqat Hussain, et al. (+3)
2 [GO] 2026―Jan―10 In-Silico Guided Design, Synthesis and Structure Activity Relationship Studies of Quinoline Based Scaffolds as Novel SARS-CoV2- Main Protease Inhibitors: Insights into Experimental and Computational Profiling Fakhria A Al-Joufi, Hayam A. Alwabsi, Mariam Ameen Mojally, Hina Sarfraz, Yousaf Khan, Asma Sardar, et al. (+7)
3 [GO] 2025―Dec―11 Deciphering the effects of Pterocarpus mildbraedii and Pterocarpus soyauxii against Sars-CoV-2 and HIV coinfection through the integration of ADMET, network pharmacology, in-silico molecular docking, pharmacophore analysis, and computational inhibition of CDK2 and HIV-1 viral proteins Owona Pascal Emmanuel, Mengue Ngadena Yolande Sandrine, Bidingha A Goufani Ronald, Bilanda Danielle Claude, Ngo Song Maguy Camille, Dzeufiet Djomeni Paul Desire, et al. (+6)
4 [GO] 2025―Mar―14 Selective Targeting of SARS-CoV-2 Mpro with Novel Ebsulfur-Based Compounds: A Computational Drug Discovery Approach Combining Molecular Dynamics and DFT Simulations Seifollah Jalili, S.M. Hossein Rahmati, Atena Pakzadiyan
5 [GO] 2025―Mar―07 Extensive In-silico Target - Ligand Conformational Space Sampling of Garlic-Derived Sulfur Compounds targeting COVID-19 infection Aldo Herrera-Rodulfo, Mariana Andrade-Medina, Martha S. Garcia-Delgado, Mauricio Carrillo-Tripp
6 [GO] 2025―Jan―18 GC-MS Analysis, Molecular Docking, Dynamics, and ADMET Profiling of Algerian Origanum vulgare Essential Oil Compounds as Potential COVID-19 Inhibitors Hanane Mouada, Mohamed Zakaria Stiti, Imran Zafar, Amira Boutarfaia, Lamia Djellaili, Fatma Lylia Berregouba, Sana Aissani
7 [GO] 2024―Sep―25 Investigating the Structure-Activity Relationship of Laulimalides Marine Macrolides as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro) Alaa M. Elgohary, Abdo A. Elfiky, Florbela Pereira, Mariam I. Gamal El-Din, Mohamed A. Tammam, Adnane Aouidate, Amr El-Demerdash
8 [GO] 2024―Aug―16 Variability in SARS-CoV-2 Spike Protein Sequences: Impact on Receptor Binding and Immunotherapeutic Strategies Aqsa Riaz, Irshad Ur Rehman, Jamshaid Ahmad, Amin Ullah, Saeed Ullah Khattak, Dalal Sulaiman Alshaya, et al. (+3)
9 [GO] 2024―Aug―01 Repurposing FDA-Approved Drugs as Potential Inhibitors of SARS-CoV-2 PLpro: A Comprehensive Computational Study Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Omar A. Soliman, Hazem Elkady, Ibrahim H. Eissa
10 [GO] 2024―Jun―17 Computational Exploration of Atriplex halimus Phytocompounds: A Targeted Approach Towards Inhibiting SARS-CoV-2 Mohammed Roubi, Mohammed Dalli, Salah-eddine Azizi, Youness Mahdi, Ramzi A. Mothana, Abdullah R. Alanzi, et al. (+2)
11 [GO] 2023―Oct―29 Novel specific SARS-CoV-2 miRNAs Targeting Human Genes involved in COVID-19 Infection and their Regulation by Bemcentinib and Zavegepant: A Promising Evidence for RNA-Based Repurposing Therapeutic Strategy Jitender Singh, Pramod K Avti, Krishan L Khanduja, Radhika Dhawan, Namrata Sangwan, Arushi Chauhan
12 [GO] 2023―Sep―16 An ensemble approach for prioritizing antivirals against COVID-19 via heterogeneous network inference-based inductive matrix completion A S Aruna, K R Remesh Babu, K Deepthi
13 [GO] 2023―Sep―04 Molecular docking and dynamics identify potential drugs to be repurposed as SARS-CoV-2 inhibitors Mohammed Muzaffar-Ur-Rehman, Chougule Kishore Suryakant, Ala Chandu, Banoth Karan Kumar, Renuka Parshuram Joshi, Snehal Rajkumar Jadav, et al. (+2)
14 [GO] 2023―Jul―26 Erratum: Designing Potential Inhibitors of SARS-CoV-2 Mpro Using Deep Learning and Steered Molecular Dynamic Simulations Nguyen Minh Tam, Linh Hoang Tran, Quan V. Vo, Minh Quan Pham, Huong Thi Thu Phung
15 [GO] 2023―Apr―10 Persistent topological Laplacian analysis of SARS-CoV-2 variants Xiaoqi Wei, Jiahui Chen, Guo-Wei Wei
16 [GO] 2023―Mar―30 Erratum - SARS-CoV-2 Main Protease Inhibitors: Structure-Based Enhancement to Anti-Viral Pre-Clinical GC376 Encourages Further Development Elliot D Perry, Simon Chapman, Yao-Zhong Xu
17 [GO] 2023―Mar―10 Designing Potential Inhibitors of SARS-CoV-2 Mpro Using Deep-Learning and Steered-Molecular Dynamic Simulations Nguyen Minh Tam, Linh Hoang Tran, Quan V. Vo, Minh Quan Pham, Huong Thi Thu Phung
18 [GO] 2022―Dec―07 SARS-CoV-2 main protease inhibitors: Structure-based enhancement to anti-viral pre-clinical GC376 encourages further development Elliot D Perry, Simon Chapman, Yao-Zhong Xu
19 [GO] 2022―Jun―17 The Candidate Molecules, RBD-ACE2 Binding Inhibitors to Prevent SARS-CoV-2 Infection M. Haluk Guven, Ali Kemal Garip
20 [GO] 2022―May―11 Targeting the SARS-CoV-2 Main protease: in silico study contributed to exploring potential natural compounds as candidate inhibitors Mourad Ounissi, Fatma Zohra Rachedi
21 [GO] 2022―Apr―29 Molecular Dynamics Simulation of Privileged Biflavonoids as SARS-CoV2 3CLpro Targeting Agents Taha Vahabzadeh, Mansour Miran, Nima Razzaghi-Asl
22 [GO] 2022―Apr―21 Insighting the Therapeutic Potential of Fifty (50) Shogaol Derivatives Against Mpro of SARS-CoV-2 Shabbir Muhammad, Saniyah Amin, Javed Iqbal, Abdullah G. Al-Sehemi, Saleh S. Alarfaji, Mubashar Ilyas, et al. (+2)
23 [GO] 2021―Nov―23 Newly identified COVID-19 drug candidates based on computational strategies Parisa Azerang, Mohsen Yazdani, Kimia RayatSanati, Azar Tahghighi
24 [GO] 2021―Nov―23 Identification of marine fungi-based antiviral agents as potential inhibitors of SARS-CoV-2 by molecular docking, ADMET and molecular dynamic study Mahnoor Qaisar, Shabbir Muhammad, Javed Iqbal, Rasheed Ahmad Khera, Abdullah G. Al-Sehemi, Saleh S. Alarfaji, et al. (+2)
25 [GO] 2021―Oct―24 Identification of Hotspot Residues in Binding of SARS-CoV-2 Spike and Human ACE2 Proteins Jenny Mendis, Ekrem Kaya, Tugba G. Kucukkal
26 [GO] 2021―Oct―12 Seven compounds from tumeric essential oil inhibits three key proteins involved in SARS-CoV-2 cell entry and replication in silico Mohamad Fawzi Mahomoodally, Sharmeen Jugreet, Gokhan Zengin, Legoabe J. Lesetja, Hassan H. Abdallah, Mohammed Oday Ezzat, et al. (+2)
27 [GO] 2021―Sep―27 Adenine Quadruplexes Show Surprising Stability: Potential Implications for SARS-CoV-2 Simon Chapman, Pierre Ghesquière, Elliot Perry, Peter Geoffrey Taylor, Nicholas P. Power, Clare E. Sansom, Yao-Zhong Xu
28 [GO] 2021―Sep―06 Usnic Acid as a Potential Free Radical Scavenger and its Inhibitory Activity Toward SARS-CoV-2 Proteins Jelena Đorović Jovanović, Nedeljko Manojlović, Zoran Marković
29 [GO] 2021―Aug―30 In Silico approaches for novel drug discovery against coronavirus by employing the hybrid molecular technique: A Review Noor ul Amin Mohsin, Muhammad Irfan, Muhammad Naeem Aamir
30 [GO] 2021―Jun―22 Molecular Docking Study of Antibiotics, Anti-Inflammatory Drugs and [Eu(TTA)3⋅AMX] Complex as COVID-19 Biomarker through Interaction of Its Main Protease (Mpro) Aluísio Marques da Fonseca, Francisco Aurecio Morais de Araújo, Rubson Mateus Matos Carvalho, Jorge Fernando Silva de Menezes, Andrei Marcelino Sá Pires Silva
31 [GO] 2021―Jun―22 Computational Discovery of SARS-CoV-2 NSP 16 Drug Candidates Based on Pharmacophore Modeling and Molecular Dynamics Simulation Zahra Hesari, Samaneh Zolghadri, Sajad Moradi, Mohsen Shahlaei, Elham Tazikeh-Lemeski
32 [GO] 2021―Jun―22 A Computational and Literature-Based Evaluation for a Combination of Chiral Anti-CoV Drugs to Block and Eliminate SARS-CoV-2 Safely Mohd. Suhail
33 [GO] 2021―Jun―11 Molecular Docking analysis of the phytochemicals from Tinospora cordifolia as potential inhibitor against multi targeted SARS-CoV-2 & Cytokine storm Debadash Panigrahi
34 [GO] 2021―Apr―28 Computational design of a potential therapeutic peptide against spike protein of SARS-CoV-2 Abbas Alibakhshi, Shahrzad Ahangarzadeh, Leila Beikmohammadi, Behnoush Soltanmohammadi, Armina Alagheband Bahrami, Mohammad mehdi Ranjbar, Elmira Mohammadi
35 [GO] 2021―Apr―15 Prevention of SARS-CoV-2 Proliferation with a Novel and Potent Main Protease Inhibitor by Docking, ADMET, MM-PBSA, and Molecular Dynamics Simulation Akbar Noorbakhsh, Rafee Habib Askandar, Mohammad Shakib Alhagh, Chiako Farshadfar, Seyed Hamid Seyedi, Mehran Ahmadizad, et al. (+3)
36 [GO] 2021―Mar―02 Virtual screening of citrus flavonoid tangeretin: a promising pharmacological tool for the treatment and prevention of Zika fever and COVID-19 Matheus Nunes da Rocha, Daniela Ribeiro Alves, Marcia Machado Marinho, Selene Maia de Morais, Emmanuel Silva Marinho
37 [GO] 2021―Feb―18 Exploration of Some Naturally Occurring Fungal-derived Bioactive Molecules as Potential SARS-CoV-2 Main Protease (MPro) Inhibitors through In-silico Approach Pradip Jana, Bhagwati Bhardwaj
38 [GO] 2020―Nov―21 Virtual screening for the identification of potential candidate molecules against envelope (E) and membrane (M) proteins of SARS-CoV-2 Abbas Alibakhshi, Mohammad Mehdi Ranjbar, Shaghayegh Haghjooy Javanmard, Fatemeh Yarian, Shahrzad Ahangarzadeh
39 [GO] 2020―Nov―17 Virtual Screening of Natural Curcumins and Related Compounds Against SARS-CoV-2 Daniela Ribeiro Alves, Matheus Nunes da Rocha, Damião Sampaio de Sousa, Iris Cristina Maia Oliveira, Marcia Machado Marinho, Selene Maia de Morais, Emmanuel Silva Marinho
 [1] 

39 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec